BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28942012)

  • 21. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
    Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
    Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
    Chung YL; Wu ML
    J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
    Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of cyclin D1 is associated with elevated levels of MAP kinases, Akt and Pak1 during diethylnitrosamine-induced progressive liver carcinogenesis.
    Parekh P; Rao KV
    Cell Biol Int; 2007 Jan; 31(1):35-43. PubMed ID: 17055752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
    Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury.
    Abe M; Yoshida T; Akiba J; Ikezono Y; Wada F; Masuda A; Sakaue T; Tanaka T; Iwamoto H; Nakamura T; Sata M; Koga H; Yoshimura A; Torimura T
    World J Gastroenterol; 2017 Oct; 23(37):6833-6844. PubMed ID: 29085226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.
    Murakami S; Ninomiya W; Sakamoto E; Shibata T; Akiyama H; Tashiro F
    Stem Cells; 2015 Sep; 33(9):2652-63. PubMed ID: 26013162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis.
    Pok S; Barn VA; Wong HJ; Blackburn AC; Board P; Farrell GC; Teoh NC
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1210-9. PubMed ID: 26574916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
    Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
    Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.
    Nayeb-Hashemi H; Desai A; Demchev V; Bronson RT; Hornick JL; Cohen DE; Ukomadu C
    Biochem Biophys Res Commun; 2015 Sep; 465(2):167-73. PubMed ID: 26225745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model.
    Srivastava J; Siddiq A; Emdad L; Santhekadur PK; Chen D; Gredler R; Shen XN; Robertson CL; Dumur CI; Hylemon PB; Mukhopadhyay ND; Bhere D; Shah K; Ahmad R; Giashuddin S; Stafflinger J; Subler MA; Windle JJ; Fisher PB; Sarkar D
    Hepatology; 2012 Nov; 56(5):1782-91. PubMed ID: 22689379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
    Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
    Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF
    J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
    Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
    Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
    Zhang S; Nguyen LH; Zhou K; Tu HC; Sehgal A; Nassour I; Li L; Gopal P; Goodman J; Singal AG; Yopp A; Zhang Y; Siegwart DJ; Zhu H
    Gastroenterology; 2018 Apr; 154(5):1421-1434. PubMed ID: 29274368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated hepatocellular carcinoma development in CUL4B transgenic mice.
    Yuan J; Jiang B; Zhang A; Qian Y; Tan H; Gao J; Shao C; Gong Y
    Oncotarget; 2015 Jun; 6(17):15209-21. PubMed ID: 25945838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.